Clinic
Centro De Hematologia Y Oncologia Del Sur, CSP
Centro De Hematologia Y Oncologia Del Sur, CSP was paid $6.24M by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is J9263, Injection, oxaliplatin, 0.5 mg — 28% of everything it billed.
33Billing provider infoCENTRO DE HEMATOLOGIA Y ONCOLOGIA DEL SUR, CSP
SANTA ISABEL, PR 00757
SANTA ISABEL, PR 00757
33aNPI1740557503assigned 11/22/2011
33bProvider typeInfusion Therapy Clinic/Center
28Total paid$6.24M
24GClaims70,471
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Infusion Therapy Clinic/Center providers in Puerto Rico
Rank by total paid#1 of 9
Median peer was paid$166K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,962 | $251K | |
| 2019 | 8,431 | $334K | |
| 2020 | 12,860 | $1.43M | |
| 2021 | 13,889 | $2.07M | |
| 2022 | 11,935 | $1.15M | |
| 2023 | 8,669 | $473K | |
| 2024incomplete | 8,725 | $529K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J9263 | Injection, oxaliplatin, 0.5 mg | 28% | 514 | 278 | $1.75M |
| Q0084 | Chemotherapy administration by infusion technique only, per visit | 19% | 12,620 | 5,405 | $1.20M |
| J9035 | Injection, bevacizumab, 10 mg | 19% | 365 | 219 | $1.18M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 9.3% | 7,084 | 3,155 | $578K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.2% | 6,009 | 4,873 | $385K |
| 96415 | 4.2% | 5,125 | 2,663 | $261K | |
| 96367 | 3.3% | 6,873 | 3,058 | $205K | |
| 96417 | 2.5% | 3,104 | 1,745 | $155K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 4,232 | 2,242 | $80K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 1,520 | 1,031 | $68K |
| J0640 | Injection, leucovorin calcium, per 50 mg | 1.1% | 833 | 418 | $66K |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 75 | 62 | $57K |
14 more codes
| 96402 | <1% | 1,349 | $42K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,717 | $40K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,479 | $39K |
| 96416 | <1% | 531 | $36K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 535 | $35K |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 1,048 | $30K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,132 | $10K |
| 96521 | <1% | 112 | $9K | |
| 99443 | <1% | 144 | $6K | |
| 96523 | <1% | 288 | $5K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 176 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 4,255 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,314 | $2K |
| 96401 | <1% | 37 | $846.41 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMATOS, NELSON (PRESIDENT)